Business Wire

Sandvik Coromant becomes DMG MORI Premium Partner

Del

Cutting tool and tooling systems specialist Sandvik Coromant has signed an agreement to become a Premium Partner of leading machine tool manufacturer, DMG MORI . The deal makes Sandvik Coromant the only tooling manufacturer to be named as a DMG MORI Premium Partner, and will serve to further strengthen the relationship between the companies on a global scale. Machine shops around the world will now benefit from the combined knowledge and experience of two market leaders.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161207006306/en/

(L-R) Dr. Masahiko Mori, CEO, DMG MORI; Klas Forsstrom, President Sandvik Coromant; Christian Thones ...

(L-R) Dr. Masahiko Mori, CEO, DMG MORI; Klas Forsstrom, President Sandvik Coromant; Christian Thones, Chairman of Executive Board, DMG MORI; Bjorn Roodzant, VP Marketing Communication; Sean Holt, General Manager Sales Area Americas (Photo: Business Wire)

As a DMG MORI Premium Partner, Sandvik Coromant will work together with the machine tool builder on initiatives such as open house events, trade show appearances, technical seminars, website collaboration and the DMG MORI Journal. Specifically, the agreement will give users of DMG MORI machines access to turning, parting and grooving, threading, milling, drilling, boring and reaming tools from Sandvik Coromant, as well as tooling systems and the company’s extensive range of knowledge, industry solutions and services.

“This agreement confirms our position as one of our industry's true premium and forward-looking companies,” says Klas Forsström, Global President of Sandvik Coromant. “As we join forces with a leading machine tool builder, for example on turnkey projects, we take an active role in advancing technology for the industry.”

Sandvik Coromant will equip DMG MORI machines right from the start of each project with a wide range of products, services and know-how. For instance, a customised start-up tool kit and service will be supplied with each NLX series universal lathe and NT turn-mill centre.

An example of the successful collaboration between Sandvik Coromant and DMG MORI can be seen when the pair recently partnered with Rota Metal, a distributor in Turkey, and its customer, Polat Makina.

Polat, a producer of decanter and separator technologies utilised for wastewater treatment, industrial, mineral and food applications, was ready to make the switch from individual machining to multi-tasking machines. Here, Sandvik Coromant was able to recommend a complete new tooling package based upon the company’s Coromant Capto® modular quick-change tooling concept. The DMG MORI machines included an NTX 2000 with Capto C6 spindle, an NT 5400 with Capto C8 spindle, and an NT 6600 with Capto C8 spindle. Further Sandvik Coromant tools specified to help complete the switch included Silent Tools®, CoroTurn® HP, CoroCut® SL, CoroDrill® 860, CoroTap® 300, CoroChuck® 970 and CoroChuck 930. The end result was reduced machining time, from 2500 to 500 minutes for a finished Duplex stainless steel product. This 80% saving is helping ensure rapid return on the company’s investment.

“Sandvik Coromant did not just supply the tools, they supplied the solution,” says Volkan Polat, deputy general manager of Polat Makina.

About Sandvik Coromant

Photo Caption: (L-R) Dr. Masahiko Mori, CEO, DMG MORI; Klas Forsström, President Sandvik Coromant; Christian Thönes, Chairman of Executive Board, DMG MORI; Björn Roodzant, VP Marketing Communication; Sean Holt, General Manager Sales Area Americas

Download image here.

www.sandvik.coromant.com

Contact information

Contact details for editorial enquiries
Sandvik Coromant
Nikki Stokes, +44 (0) 121 504 5422
PR & Advertising
nikki.stokes@sandvik.com
or
Publitek (Pinnacle Division)
Birgit Schöniger, +44 (0) 208 429 6554
Account Director
birgit.schoeniger@publitek.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers17.2.2018 21:00Pressemelding

Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im

CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 08:00Pressemelding

Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates

Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 18:26Pressemelding

Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a

General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 17:05Pressemelding

General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges

Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 09:03Pressemelding

Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o

Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 08:00Pressemelding

Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and